Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $1.4M | 6 | 86.7% |
| Consulting Fee | $192,352 | 22 | 12.1% |
| Travel and Lodging | $10,952 | 29 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,525 | 1 | 0.3% |
| Unspecified | $1,714 | 1 | 0.1% |
| Food and Beverage | $1,390 | 29 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1.4M | 8 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $85,663 | 35 | $0 (2023) |
| Global Blood Therapeutics, Inc. | $77,061 | 8 | $0 (2022) |
| Celgene Corporation | $29,513 | 17 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $7,375 | 7 | $0 (2019) |
| F. Hoffmann-La Roche AG | $6,266 | 4 | $0 (2023) |
| Agios Pharmaceuticals, Inc. | $3,300 | 1 | $0 (2020) |
| bluebird bio, Inc. | $2,404 | 3 | $0 (2023) |
| APO-PHARMA USA, INC. | $50.00 | 1 | $0 (2018) |
| Boston Scientific Corporation | $27.07 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.39 | 2 | PFIZER INC. ($148.58) |
| 2023 | $90,251 | 40 | Vertex Pharmaceuticals Incorporated ($81,533) |
| 2022 | $1.4M | 13 | PFIZER INC. ($1.4M) |
| 2021 | $29,555 | 6 | Global Blood Therapeutics, Inc. ($28,292) |
| 2020 | $7,050 | 2 | Celgene Corporation ($3,750) |
| 2019 | $30,318 | 22 | Celgene Corporation ($24,632) |
| 2018 | $114.65 | 2 | PFIZER INC. ($64.65) |
| 2017 | $1,714 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,714) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $148.58 | General |
| Category: HEMATOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $5,880.00 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $25,200.00 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $673.10 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $234.90 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $39.84 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $13.45 | General |
| 11/20/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $9.26 | General |
| 11/11/2023 | Boston Scientific Corporation | EMBOLD Fibered (Device) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Embold_PI | ||||||
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $9,240.00 | General |
| 11/02/2023 | bluebird bio, Inc. | SKYSONA (Drug), Zynteglo | Consulting Fee | Cash or cash equivalent | $1,700.00 | General |
| Category: cerebral-adrenoleukodystrophy | ||||||
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $378.47 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $326.64 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $28.94 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $27.70 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $12.63 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $8.19 | General |
| 11/02/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $6.75 | General |
| 10/18/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $16,800.00 | General |
| 10/18/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $756.94 | General |
| 10/18/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $410.08 | General |
| 10/18/2023 | Vertex Pharmaceuticals Incorporated | — | Travel and Lodging | In-kind items and services | $29.03 | General |
| 10/18/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 09/07/2023 | bluebird bio, Inc. | SKYSONA (Drug), Zynteglo | Consulting Fee | Cash or cash equivalent | $680.00 | General |
| Category: cerebral-adrenoleukodystrophy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,714 | 1 |
About Dr. Alexis Thompson, MD
Dr. Alexis Thompson, MD is a Pediatric Hematology-Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467420737.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexis Thompson, MD has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $163.39 received in 2024. These payments were reported across 88 transactions from 13 companies. The most common payment nature is "Acquisitions" ($1.4M).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Chicago, IL
- Active Since 03/10/2006
- Last Updated 09/29/2011
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1467420737
Products in Payments
- OXBRYTA (Drug) $77,210
- Luspatercept (Drug) $19,017
- ADAKVEO (Biological) $5,222
- REBLOZYL (Biological) $4,881
- SKYSONA (Drug) $2,380
- EXJADE (Drug) $1,714
- DEFERIPRONE (Drug) $50.00
- EMBOLD Fibered (Device) $27.07
- Zynteglo (Drug) $23.55
- ULTOMIRIS (Biological) $20.46
- TRELEGY ELLIPTA (Drug) $14.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Chicago
James Labelle
Pediatric Hematology-Oncology — Payments: $249,251
Sherif Badawy, Md, MD
Pediatric Hematology-Oncology — Payments: $207,866
Dr. Loretta Li, M.d, M.D
Pediatric Hematology-Oncology — Payments: $187,559
Susan Cohn
Pediatric Hematology-Oncology — Payments: $125,685
Leonard Valentino, M.d, M.D
Pediatric Hematology-Oncology — Payments: $117,453
Dr. Miriam Bornhorst, Md, MD
Pediatric Hematology-Oncology — Payments: $69,696